Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Timing of trials

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Dec 10, 2020 1:02pm

98 Views

Post# 32077633

RE:RE:RE:Timing of trials

Q-1 has to mean THTX Q-1 Not calendar year Q-1

SPCEO1 wrote: I have an easy fix for that - TH should change its reporting to a calendar year end from November year end. For analysts, it makes life so much easier.

Meanwhile, I think you can assume that he is using normal calendar terminolgy and not fiscal year terminology. But I could be wrong about that as they are not always consistent on that and it has caused me some confusion in the past too.

SABBOBCAT wrote: I think Paul and TH need to be clearer in their communication. Right now it seems they may be mixing terminology that clouds the picture for those of us looking to establish a timeline. In reading the terms "year end" or "in Q1", I would interpret that as fiscal year terminology that refers to November YE and February Q1. On the other hand specifics of before the end of December 2020 or March 2021 should be used if they are referencing the calendar year. If they are using the terms properly and are referring to the fiscal year, they should have filed the INDs and the trials should start before February